News

Title Content Date
CureVac Secures €80 Million in Series D Financing CureVac GmbH, a clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, today announced 18.09.2012
Curetis AG and Cempra, Inc. Collaborate on the Detection of Community-Acquired Bacterial Pneumonia Pathogens Curetis AG and Cempra Inc. 15.08.2012
Résumé of First SIG Event The first of five Biomat-IN SIG events took place in Nottingham/England at the end of June. 16.07.2012
Insilico and Metabolomic Discoveries Launch Media Optimization Kit and Cell Line Engineering Kit Metabolomic Discoveries and Insilico Biotechnology have launched two innovative products, jointly developed to optimize bioproduction processes: the Media Optimization Kit and Cell Line Engineering 18.06.2012
immatics presents encouraging overall survival data from a phase 2 study in Advanced Colorectal Cancer at the ASCO Annual Meeting Tuebingen, June 1, 2012 – immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that its 04.06.2012
immatics wins 2012 TiE50 Award immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that it has been named a 2012 TiE5 25.05.2012
immatics appoints Dr Rainer Kramer as Chief Business Officer immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing therapeutic vaccines that are active against cancer, today announced the appointment of Dr. 12.04.2012
Insilico on the fast track: Supercomputer breaks into new high performance dimensions “Hermit“, the new supercomputer, was put into action in HLRS, the High Performance Computing Center in Stuttgart, in February 2012. The event was crowned by the presence of Prof.Dr. 03.04.2012
Seeing movement: Why the world in our head stays still when we move our eyes When observing a fly buzzing around the room and following it around with the eyes, we ought to have the impression that it is not the fly, but rather the space that lies behind it that is moving. 28.03.2012
Protagen and NMI announce Co-Development of Multiplex Assays "Protagen has a unique expertise in high-throughput expression of human proteins and the conduct of clinical validation studies for serum biomarkers. 19.03.2012

Pages